A novel model for Ki67 assessment in breast cancer.
Författare
Summary, in English
Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.
Avdelning/ar
- Bröstcancer-genetik
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Tumörmikromiljö
Publiceringsår
2014
Språk
Engelska
Publikation/Tidskrift/Serie
Diagnostic Pathology
Volym
9
Issue
1
Fulltext
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
BioMed Central (BMC)
Ämne
- Cancer and Oncology
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1746-1596